Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP
The human T-cell lymphotropic virus type 1 (HTLV-1) is the known causative agent of a chronic neurologic condition known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although several therapies have been evaluated for HAM/TSP, none have been approved for use in humans. In t...
Saved in:
| Main Authors: | Davi Tanajura Costa, Michael Sundberg, Lúcia Passos, André Luiz Muniz, Silvane Santos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Neurological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2012/958786 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficulties in HAM/TSP diagnosis
by: Carla Maria Sena Andrade Slater, et al.
Published: (2012-09-01) -
Considerations on HAM/TSP: rediscovering Tumaco
by: Noboru Yasuda
Published: (1993-03-01) -
Use of Western blot test for analysis of cerebrospinal fluid in HAM/TSP
by: Luiz Claudio Pereira Ribeiro
Published: (2010-02-01) -
Lymphocyte alveolitis in HAM/TSP patients: preliminary report
by: K. Mattos, et al.
Published: (1993-03-01) -
Implications of HAM/TSP functional incapacity in the quality of life
by: Marcia Shublaq, et al.
Published: (2011-04-01)